These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36003068)

  • 21. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
    Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
    Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma.
    Wang W; Wang L; Xie X; Yan Y; Li Y; Lu Q
    BMC Cancer; 2021 Jan; 21(1):6. PubMed ID: 33402113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low expression of moonlight gene ALAD is correlated with poor prognosis in hepatocellular carcinoma.
    Ye Q; Yang X; Zheng S; Mao X; Shao Y; Xuan Z; Huang P
    Gene; 2022 May; 825():146437. PubMed ID: 35318110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.
    Liu T; Wu H; Qi J; Qin C; Zhu Q
    Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a Combined Oxidative Stress and Endoplasmic Reticulum Stress-Related Prognostic Signature for Hepatocellular Carcinoma.
    Ma H; Li Z; Chen R; Ren Z
    Comb Chem High Throughput Screen; 2023 Nov; ():. PubMed ID: 37957902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma.
    Zhou X; Liu C; Zeng H; Wu D; Liu L
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33835133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
    Yang Z; Zi Q; Xu K; Wang C; Chi Q
    Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma.
    Kong J; Yu G; Si W; Li G; Chai J; Liu Y; Liu J
    BMC Cancer; 2022 Feb; 22(1):142. PubMed ID: 35123420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
    BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

  • 31. A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells.
    Wang Y; Yang Y; Zhao Z; Sun H; Luo D; Huttad L; Zhang B; Han B
    BMC Cancer; 2022 Apr; 22(1):379. PubMed ID: 35397536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm.
    Wang T; Dai L; Shen S; Yang Y; Yang M; Yang X; Qiu Y; Wang W
    Front Immunol; 2022; 13():843408. PubMed ID: 35693827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
    Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
    J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy.
    Wu H; Liu TT; Feng YM; Xie XY; Su XN; Qi JN; Zhu Q; Qin CY
    J Dig Dis; 2020 Nov; 21(11):650-663. PubMed ID: 32959529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of a Novel Clinical Stage-Related Gene Signature for Predicting Outcome and Immune Response in Hepatocellular Carcinoma.
    Yang L; Zeng LF; Hong GQ; Luo Q; Lai X
    J Immunol Res; 2022; 2022():6535009. PubMed ID: 35865652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying a Novel Endoplasmic Reticulum-Related Prognostic Model for Hepatocellular Carcinomas.
    Ding F; Li J; Zhang Y; Wang C; Yu Y
    Oxid Med Cell Longev; 2022; 2022():8248355. PubMed ID: 35915607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.
    Li R; Zhao W; Liang R; Jin C; Xiong H
    Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972
    [No Abstract]   [Full Text] [Related]  

  • 38. Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma.
    Wu ZH; Yang DL; Wang L; Liu J
    Front Immunol; 2021; 12():793343. PubMed ID: 34925377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
    Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
    World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma.
    Xu Q; Wang Y; Huang W
    Int Immunopharmacol; 2021 Mar; 92():107333. PubMed ID: 33486322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.